CPC Scientific is Back at CPHI Frankfurt 2025!

October 28, 2025

CPC Scientific is thrilled to return to CPHI Frankfurt 2025, taking place from Oct. 28–30 at Messe Frankfurt, Germany. As one of the largest global gatherings in the pharma development and manufacturing ecosystem, CPHI is the ideal platform to highlight our position as a pioneering leader in peptide and oligonucleotide CDMO services.

CPC Scientific explores GMP peptide manufacturing, oligonucleotide conjugation, commercial production, generic API scale-up and more at CPHI 2025

Inside the Booth: Day 1 at CPHI Frankfurt

Take a quick video tour of our setup at Booth #12.0F29 as our team members walk you through our exhibition and meeting space, where many dynamic conversations and collaborations have already kicked off on Day 1:

From the moment the doors opened this morning, we’ve welcomed a steady stream of visitors at our booth, with teams stopping by to dive into everything from complex peptide synthesis and oligo conjugation, to large-scale commercial production.

Some of the standout themes from today included:

  • Our expanded focus on generic API scale-up with support for partners worldwide
  • Our upcoming Rocklin, California manufacturing facility, as part of our global supply chain expansions for late phase and commercial production

These conversations reinforce what drives our approach at CPC Scientific: innovation, partnership, and proven performance. As a globally trusted CDMO partner, we’re here to empower and accelerate our clients’ breakthroughs, from development through commercial supply.

As a pioneering peptide and oligo manufacturer, CPC Scientific advances global partnerships, leadership, and innovation at CPHI Frankfurt

Meet CPC Scientific at CPHI 2025

CPC Scientific is exhibiting in the API Hall at Booth #12.0F29 through Thursday, Oct. 30. Look for our team members on-site:

If we haven’t met yet, we’d love to connect with you. Stop by Booth #12.0F29 through Thursday, Oct. 30 and enjoy some of our exclusive goodies (bears, tote bags, white papers, and more!).

Shawn Lee, Theresa Cheng, and the CPC Scientific team at CPHI Frankfurt 2025, showcasing peptide and oligonucleotide CDMO and GMP manufacturing expertise

Can’t make it to Frankfurt? We’d still love to chat. Reach out to our team at sales@cpcscientific.com and we’ll set up a time that works for you.

Looking Ahead

It’s been a fantastic start to the event so far! We’re truly inspired by the innovators we’ve connected with and the spirit of cutting-edge collaboration that defines the global biotech and pharma ecosystem.

Our exchanges at CPHI Frankfurt continue to reaffirm our commitment to advancing life-saving technologies that bring safer and more effective peptide NCE, oligonucleotide NCE, and generic API therapies to patients worldwide.

Shawn Lee, Sheri Ambriz, and Tim Nieters discuss CPC Scientific's upcoming US manufacturing expansions in Rocklin, California as part of our global API supply chain expansion, on Day 1 of CPHI Frankfurt 2025

Day 2 kicks off tomorrow, and our calendar is filling quickly. If you’re in Frankfurt, don’t miss the chance to meet with our team at Booth #12.0F29 before the event wraps up on Oct. 30!

Latest News & Resources

With nearly 25 years of experience, our group is a globally recognized Contract Research, Development, and Manufacturing Organization (CRDMO) that specializes in synthetic GMP peptides, oligonucleotides, and peptide-oligonucleotide conjugates (POCs), while offering a full range of research-grade custom and catalog products. Our integrated service model is designed to support partners through the most critical phases of drug development, with a particular focus on late-phase development, large-scale manufacturing, and commercial production. From initial discovery to full commercialization, we provide the expertise and robust infrastructure to accelerate peptide and oligonucleotide programs to success, backed by metric-ton scale GMP manufacturing and an annual production capacity exceeding 1,000 kg.

CPC Scientific meticulously follows FDA and ICH guidelines for CGMP manufacturing, and we provide complete support for your IND, NDA, and BLA filings in the USA and all international filings and required regulatory support for your active pharmaceutical ingredients (APIs). Our New Chemical Entity (NCE) development program involves process development, process validation, analytical method development, method validation, stability studies, regulatory support, and assistance preparing regulatory documents. We also have flexibility, pre-qualified workspace, and robust supply chain to incorporate new projects into our pipeline rapidly. We understand that delivery time is critical to your project’s success, and we have the capacity and flexibility to accept new projects and initiate production sooner than many leading CDMOs.

With a USA facility in Rocklin, near Sacramento, California, CPC Scientific is a subsidiary of Medtide Inc., which officially listed on the main board of the Hong Kong Stock Exchange in 2025.

Latest News & Resources from CPC Scientific

Sign up for CPC Scientific’s newsletter